http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 02 Jun 2026 07:00:53 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/HeartBeam+study+shows+ECG+device+may+help+assess+heart+attack+risk+at+home/26587218.html <p>HeartBeam Inc. (NASDAQ: BEAT) announced a peer-reviewed study published in JACC: Advances demonstrating that an algorithm combining its portable ECG device with patient risk factors can identify heart attack risk in patients with chest pain.</p><p>The proof-of-concept study, led by Dr. Alexei Shvilkin at Beth Israel Deaconess Medical Center, enrolled 212 patients presenting to emergency departments with chest pain, with 184 included in the final analysis. The research evaluated whether combining ECG data from HeartBeam's credit card-sized device with patient risk factors and symptoms could match physician assessments using traditional 12-lead ECGs.</p><p>The algorithm achieved an area under the curve (AUC) of http://www.streetinsider.com/Corporate+News/HeartBeam+study+shows+ECG+device+may+help+assess+heart+attack+risk+at+home/26587218.html Tue, 02 Jun 2026 07:00:53 -0400 BEAT http://www.streetinsider.com/FDA/HeartBeam+study+shows+ECG+device+may+help+assess+heart+attack+risk+at+home/26587218.html <p>HeartBeam Inc. (NASDAQ: BEAT) announced a peer-reviewed study published in JACC: Advances demonstrating that an algorithm combining its portable ECG device with patient risk factors can identify heart attack risk in patients with chest pain.</p><p>The proof-of-concept study, led by Dr. Alexei Shvilkin at Beth Israel Deaconess Medical Center, enrolled 212 patients presenting to emergency departments with chest pain, with 184 included in the final analysis. The research evaluated whether combining ECG data from HeartBeam's credit card-sized device with patient risk factors and symptoms could match physician assessments using traditional 12-lead ECGs.</p><p>The algorithm achieved an area under the curve (AUC) of http://www.streetinsider.com/FDA/HeartBeam+study+shows+ECG+device+may+help+assess+heart+attack+risk+at+home/26587218.html Tue, 02 Jun 2026 07:00:53 -0400 BEAT http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Press+Releases/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html <ul class="bwlistdisc"> <li> <i>Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk</i> </li> <li> <i>Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack detection</i> </li> <li> <i>Large market potential with over 20 million patients in the U.S. at risk of a heart attack</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54545891&amp;newsitemid=20260602704375&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=2eacbfa995be7d604bea1155da1f1845" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in <i>JACC: Advances</i>, a journal of the American College of Cardiology, demonstrating http://www.streetinsider.com/Business+Wire/HeartBeam+Announces+New+Peer-Reviewed+Article+Demonstrating+Potential+to+Help+Identify+Heart+Attack+Risk+at+Home/26587153.html Tue, 02 Jun 2026 07:00:00 -0400 A.12013808 A.60012013 BEAT O.03960647 O.16534670 O.52737737 http://www.streetinsider.com/Analyst+PT+Change/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%242.50+at+H.C.+Wainwright/26538366.html (Updated - May 22, 2026 6:51 AM EDT) <p>H.C. Wainwright analyst Yi Chen lowered the price target on Heartbeam Inc. (NASDAQ: BEAT) to $2.50 (from $5.50) while maintaining a Buy rating.</p><p>The analyst commented: "HeartBeam recently reported its 1Q26 financial results. No revenue was recognized in the quarter, compared to our projection of $100K. Net loss was $4.7M, or ($0.12) per share, less than our estimated loss of $5.6M. Though a limited market release of the 12-lead electrocardiogram (ECG) synthesis software for the assessment of arrhythmias is underway, the company is currently in the phase of onboarding flagship accounts, according to management. http://www.streetinsider.com/Analyst+PT+Change/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%242.50+at+H.C.+Wainwright/26538366.html Fri, 22 May 2026 06:51:48 -0400 BEAT http://www.streetinsider.com/Analyst+Comments/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%242.50+at+H.C.+Wainwright/26538366.html (Updated - May 22, 2026 6:51 AM EDT) <p>H.C. Wainwright analyst Yi Chen lowered the price target on Heartbeam Inc. (NASDAQ: BEAT) to $2.50 (from $5.50) while maintaining a Buy rating.</p><p>The analyst commented: "HeartBeam recently reported its 1Q26 financial results. No revenue was recognized in the quarter, compared to our projection of $100K. Net loss was $4.7M, or ($0.12) per share, less than our estimated loss of $5.6M. Though a limited market release of the 12-lead electrocardiogram (ECG) synthesis software for the assessment of arrhythmias is underway, the company is currently in the phase of onboarding flagship accounts, according to management. http://www.streetinsider.com/Analyst+Comments/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%242.50+at+H.C.+Wainwright/26538366.html Fri, 22 May 2026 06:51:48 -0400 BEAT http://www.streetinsider.com/Analyst+PT+Change/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%245+at+Benchmark+After+Q1+Results/26499564.html <p>Benchmark analyst Bill Sutherland lowered the price target on Heartbeam Inc. (NASDAQ: BEAT) to $5.00 (from $8.00) while maintaining a Speculative Buy rating.</p><p>The analyst commented, "With 1Q results, HeartBeam provided a solid update that included 1) expanded the initial commercial launch of its hand-held 12-lead ECG for arrhythmia assessment to four markets with the signing of a second concierge/preventive cardiology practice; 2) completed a working prototype and initiated a pilot study for its 12-lead extended wear patch that is positioned to disrupt the $2B MCT monitoring market; 3) reported patient enrolment for a pilot study evaluating the HeartBeam system for http://www.streetinsider.com/Analyst+PT+Change/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%245+at+Benchmark+After+Q1+Results/26499564.html Fri, 15 May 2026 07:51:53 -0400 BEAT http://www.streetinsider.com/Analyst+Comments/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%245+at+Benchmark+After+Q1+Results/26499564.html <p>Benchmark analyst Bill Sutherland lowered the price target on Heartbeam Inc. (NASDAQ: BEAT) to $5.00 (from $8.00) while maintaining a Speculative Buy rating.</p><p>The analyst commented, "With 1Q results, HeartBeam provided a solid update that included 1) expanded the initial commercial launch of its hand-held 12-lead ECG for arrhythmia assessment to four markets with the signing of a second concierge/preventive cardiology practice; 2) completed a working prototype and initiated a pilot study for its 12-lead extended wear patch that is positioned to disrupt the $2B MCT monitoring market; 3) reported patient enrolment for a pilot study evaluating the HeartBeam system for http://www.streetinsider.com/Analyst+Comments/Heartbeam+Inc.+%28BEAT%29+PT+Lowered+to+%245+at+Benchmark+After+Q1+Results/26499564.html Fri, 15 May 2026 07:51:53 -0400 BEAT http://www.streetinsider.com/Earnings/HeartBeam%2C+Inc+%28BEAT%29+Tops+Q1+EPS+by+2c/26485712.html <p>HeartBeam, Inc (NASDAQ: BEAT) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14).</p><p>For earnings history and earnings-related data on HeartBeam, Inc (BEAT) <a href="http://www.streetinsider.com/ec_earnings.php?q=BEAT">click here</a>.</p> http://www.streetinsider.com/Earnings/HeartBeam%2C+Inc+%28BEAT%29+Tops+Q1+EPS+by+2c/26485712.html Wed, 13 May 2026 16:02:15 -0400 BEAT http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Mar+31/26485731.html si-local-file:///var/storage/secattach/20260513/26485731.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Mar+31/26485731.html Wed, 13 May 2026 16:02:00 -0400 BEAT O.52737737 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Mar+31/26485731.html si-local-file:///var/storage/secattach/20260513/26485731.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Mar+31/26485731.html Wed, 13 May 2026 16:02:00 -0400 BEAT O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html <ul class="bwlistdisc"> <li> <i>Signed First Commercial Partners in Leading Concierge Practices ClearCardio™ and Atelier Health</i> </li> <li> <i>Established Flagship Commercial Sites Across New York, Dallas, South Florida and Southern California</i> </li> <li> <i>Strategic Collaboration with Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms, Starting with Heart Attack Detection</i> </li> <li> <i>Strengthened Balance Sheet with $11.5 Million Public Offering Including Full Exercise of Over-Allotment Option</i> </li> <li> <i>Initiated Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Initiated Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54535264&amp;newsitemid=20260513180482&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=ce0a987773a37a2972978a79e8d8872d" http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html Wed, 13 May 2026 16:01:00 -0400 A.23636062 BEAT O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html <ul class="bwlistdisc"> <li> <i>Signed First Commercial Partners in Leading Concierge Practices ClearCardio™ and Atelier Health</i> </li> <li> <i>Established Flagship Commercial Sites Across New York, Dallas, South Florida and Southern California</i> </li> <li> <i>Strategic Collaboration with Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms, Starting with Heart Attack Detection</i> </li> <li> <i>Strengthened Balance Sheet with $11.5 Million Public Offering Including Full Exercise of Over-Allotment Option</i> </li> <li> <i>Initiated Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Initiated Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54535264&amp;newsitemid=20260513180482&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=ce0a987773a37a2972978a79e8d8872d" http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html Wed, 13 May 2026 16:01:00 -0400 A.23636062 BEAT O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html <ul class="bwlistdisc"> <li> <i>Signed First Commercial Partners in Leading Concierge Practices ClearCardio™ and Atelier Health</i> </li> <li> <i>Established Flagship Commercial Sites Across New York, Dallas, South Florida and Southern California</i> </li> <li> <i>Strategic Collaboration with Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms, Starting with Heart Attack Detection</i> </li> <li> <i>Strengthened Balance Sheet with $11.5 Million Public Offering Including Full Exercise of Over-Allotment Option</i> </li> <li> <i>Initiated Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Initiated Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54535264&amp;newsitemid=20260513180482&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=ce0a987773a37a2972978a79e8d8872d" http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html Wed, 13 May 2026 16:01:00 -0400 A.23636062 BEAT O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html <ul class="bwlistdisc"> <li> <i>Signed First Commercial Partners in Leading Concierge Practices ClearCardio™ and Atelier Health</i> </li> <li> <i>Established Flagship Commercial Sites Across New York, Dallas, South Florida and Southern California</i> </li> <li> <i>Strategic Collaboration with Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms, Starting with Heart Attack Detection</i> </li> <li> <i>Strengthened Balance Sheet with $11.5 Million Public Offering Including Full Exercise of Over-Allotment Option</i> </li> <li> <i>Initiated Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Initiated Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54535264&amp;newsitemid=20260513180482&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=ce0a987773a37a2972978a79e8d8872d" http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+First+Quarter+2026+Results/26485661.html Wed, 13 May 2026 16:01:00 -0400 A.23636062 BEAT O.41740509 O.52737737